The Brain Health Revolution Podcast cover image

Year 2022 Review: Exciting Findings in the Field of Neurology and Neuroscience

The Brain Health Revolution Podcast

00:00

Alzheimer's Drug - Cannabab

FDA recently approved a monoclonal antibody, which is now touted as the first Alzheimer's drugs that is going to be available for patients. The administration of this antibody reduced the load of amyloid in patients with early Alzheimer's pathology. After 18 months, there was a 27% slower decline in cognitive scores among participants who received the cannabab compared to those who got placebo.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner